title: [Non-invasive methods for evaluating reperfusion in acute myocardial infarct: enzymes and MIBI-SPECT cardiac gammagraphy].
abstract: BACKGROUND
  Several studies point out the importance of what is called rescue angioplasty or fibrinolysis when thrombolysis has been ineffective in acute myocardial infarction. Therefore, it is necessary to make use of new non-invasive methods to asses reperfusion and to safely establish that such a treatment has not been effective.
  
  
  METHODS
  We present a work which is based on the assessment of patients with acute myocardial infarction treated with or without fibrinolysis. After determining cardiac enzymatic profiles of creatine kinase and MB isoform (time course, peak, appearance rate constant time-activity: K1). With cardiac imaging gammagraphies 99mTc-isonitrile-single-photon emission computed tomography pre and post treatment after to calculating myocardium at risk, salvage and relationship.
  
  
  RESULTS
  In patients treated with fibrinolysis, the salvage myocardium was higher (8.3% vs 3.0%; p < 0.05). Considering that an improvement in perfusion defect (salvaged myocardium/myocardium at risk) higher than 30% can be viewed as an effective reperfusion, we can see that the percentage in the group treated with fibrinolysis being 45.8%, and the percentage in the group under conventional treatment being just 6.7%. Patients with acute myocardial infarction treated with fibrinolysis show much shorter start of rise-peak time and pain-peak time, all this with very significant differences for the creatine kinase (p < 0.0001) as well as for the MB (p < 0.001). Patients with reperfusion show a rapid increase in activity enzymatic, as demonstrated by the pain-peak time variable and the appearance rate constant time-activity (K1), with very significant differences in the latter (p < 0.0001). In relation with gammagraphy, values of K1 higher or equal to 0.19 for the creatine kinase and 0.14 for the MB isoform, achieved a sensibility of 83% and 91%, and a specificity of 85% and 80% respectively, to asses reperfusion.
  
  
  CONCLUSIONS
  We think that cardiac imaging gammagraphy with isonitriles as well as as determination of the appearance rate enzymatic constant time-activity, can be useful in monitoring treatment with fibrinolysis in infarction patients. New studies are needed to assess these same aspects, with a lesser number of enzymatic determinations.
authors.affiliation: Servicio de Medicina Intensiva, Hospital Clínico Universitario, Zaragoza.
authors.forename: J J
authors.initials: JJ
authors.lastname: Araiz Burdio
authors.forename: G
authors.initials: G
authors.lastname: Rodrigo Trallero
authors.forename: J L
authors.initials: JL
authors.lastname: Calderero Abad
authors.forename: A
authors.initials: A
authors.lastname: Millastre Benito
authors.forename: E
authors.initials: E
authors.lastname: Civeira Murillo
authors.forename: M A
authors.initials: MA
authors.lastname: Suárez Pinilla
mesh_terms: D000368:Aged; D000075202:Contraindications; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D006801:Humans; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging* / Q000188:drug therapy* / Q000201:enzymology; D015425:Myocardial Reperfusion; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D015912:Thrombolytic Therapy
chemical_list: D007527:Isoenzymes; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D003402:Creatine Kinase